Method for cleaving amide bonds

ABSTRACT

A method for cleaving amide bonds, including: a) providing a molecule including an amide group; b) reacting the molecule including the amide group with a hydroxylamine salt to cleave the amide bond of the amide group. The method may further include c) recovering a product formed by the reaction of step b).

TECHNICAL FIELD OF THE INVENTION

The present invention relates to methods for cleaving amide bonds inorganic molecules comprising amide groups. Such methods find use invarious organic synthetic applications, e.g. for deacetylation.

BACKGROUND OF THE INVENTION

Traditional methods to cleave amide bonds via saponfication orhydrolysis are harsh processes requiring strongly basic conditions (i.e.concentrated NaOH or the like) or strongly acidic conditions (i.e.concentrated HCl or the like) at elevated temperatures for long periodsof time. Because of the harsh conditions required, these methods havemajor chemical compatability issues with regard to protecting groups andto preservation of chiral centers during the reaction.

Among the more recent methods cited is hydrazinolysis. Hydrazine permitsthe cleavage of amide bonds under almost anhydrous conditions. Hydrazineis a powerful nucelophile thanks to the alpha effect, and its reducedbasicity as compared to NaOH permits the cleavage of amide bonds in thepresence of other protecting groups and the preservation of certainchiral centres. This was recently highlighted in two high profilepublications from Ohshima et al. (Angew. Chem. Int. Ed. 2012, 51,8564-8567 and Chem. Commun., 2014, 50, 12623-12625). In these twocommunications Ohshima used ethylene diamine and hydrazine in thepresence of ammonium salts, respectively, under microwave irradiation tocleave amide bonds while maintaining other sensitive protecting groupsand chiral centers.

Even in the light of the recent findings of Ohshima et al. there isstill a need in the field for improved and methods allowing for cleavageof amide bonds while preserving protecting groups and chiral centres.

SUMMARY OF THE INVENTION

It is an object of the present invention to provide a method forcleaving amide bonds which can alleviate at least some of the problemsin the prior art.

It is an object of the present invention to provide a method forcleaving amide bonds which allows for cleavage of amide bonds whilepreserving protecting groups and/or chiral centres.

It is a further object of the present invention to provide a method forcleaving amide bonds which does not require strongly basic conditions(i.e. concentrated NaOH or the like) or strongly acidic conditions (i.e.concentrated HCl or the like) at elevated temperatures for long periodsof time.

According to aspects illustrated herein, there is provided a method forcleaving amide bonds, comprising:

a) providing a molecule comprising an amide group;

b) reacting the molecule comprising an amide group with hydroxylamine(NH₂OH) or a salt thereof to cleave the amide bond of the amide group.

The method preferably involves the use of a hydroxylamine salt.

The inventors have surprisingly found that when a hydroxylamine salt isused instead of hydroxylamine itself, the same or even higher reactionrate can be achieved with a significantly lower molar concentration ofthe reagent and/or lower pH. This means that the hydroxylamine saltsallow for the cleavage of amide bonds under less harsh reactionconditions than hydroxylamine itself, resulting in less risks ofdegradation or undesired side reactions in the amide group containingcompound. In practice, this allows for cleavage of different types ofamide bonds, including amide bonds in amides that are typicallydifficult to cleave, such as in secondary amide groups. It also allowsfor cleavage of amide groups in various “sensitive” substrates, i.e.substrates including other bonds that would easily be cleaved underharsher reaction conditions. Examples include substrates comprising pHsensitive protecting groups or pH sensitive chiral centers.

An “amide group” as referred to herein, is a compound with thefunctional group R_(n)E(O)_(x)NR′₂ (wherein R and R′ refer to H ororganic groups). Most common are carboxamides (organic amides) (n=1,E=C, x=1), but other important types of amides are known, includingphosphoramides (n=2, E=P, x=1 and many related formulas) andsulfonamides (E=S, x=2) (IUPAC, Compendium of Chemical Terminology, 2nded. (the “Gold Book”) (1997)). The term amide refers both to classes ofcompounds and to the functional group R_(n)E(O)_(x)NR′₂ within thosecompounds. The bond between the nitrogen atom and the E in the amidegroup is referred to herein as the “amide bond”. Amides should not beconfused with imides, which comprise two acyl groups bound to the samenitrogen atom, and which are comparatively easy to cleave.

Thus, in some embodiments the “amide group” is a carboxamide group, asulfonamide group or a phosphoramide group. The inventive method hasbeen found to be particularly useful for cleaving amides which aretypically more difficult to cleave, such as carboxamides orsulfonamides. Accordingly, in some embodiments the “amide group” is acarboxamide group or a sulfonamide group. In a preferred embodiment, the“amide group” is a carboxamide group. Carboxamides are derived from acarboxylic acid and an amine.

The present invention is based on the inventive realization thathydroxylamine (NH₂OH) and especially salts thereof can advantageously beused for cleavage of amide bonds in molecules comprising amide groupsunder mild reaction conditions. This allows for cleavage of amide bondswhile avoiding undesired degradation of the molecule and preservingprotecting groups and/or chiral centres. The reaction is illustratedgenerally by reaction scheme I.

For example, polysaccharides, and particularly glycosaminoglycans suchas hyaluronic acid, chondroitin and chondroitin sulfate, are often proneto degradation of the backbone under harsh reaction conditions (e.g.very high or low pH, or high temperatures). The inventive method istherefore especially useful for cleavage of amide bonds in suchpolysaccharides. The inventive method is for example useful forobtaining at least partially deacetylated glycosaminoglycans in which asignificant portion of the molecular weight of the starting material isretained. Using hydroxylamine or salts thereof for deacetylation hasbeen found to allow for N-deacetylation under mild conditions resultingin only minor degradation of the polymeric backbone of hyaluronic acid.Using hydroxylamine or salts thereof for deacetylation thus allows forproduction of deacetylated hyaluronic acid with retained high molecularweight. This is in contrast to previously known methods, such asdeacetylation using hydrazine or NaOH as the deacetylating agent, wherehigh degrees of deacetylation have been inevitably accompanied by severedegradation of the polymeric backbone.

The inventive method is useful for cleaving amide bonds in primary,secondary and tertiary amide groups. A primary amide refers to an amidein which the amide nitrogen is bound to one carbon atom. A secondaryamide refers to an amide in which the amide nitrogen is bound to twocarbon atoms. A tertiary amide refers to an amide in which the amidenitrogen is bound to three carbon atoms. The method is particularlyadvantageous for cleaving amide bonds in more hindered amides, i.e.secondary and tertiary amide groups, since such bonds are typically moredifficult to cleave using conventional methods. Thus, according toembodiments, the amide group is a primary, secondary or tertiary amidegroup, preferably a secondary amide group.

The inventive method may also be particularly useful for deacylation,particularly deacetylation, of molecules comprising acyl or acetylgroups. Thus, according to embodiments, the amide group is an N-acylamide group, preferably an N-acetyl amide group.

According to embodiments, the molecule comprising an amide group furthercomprises a pH sensitive chiral center. Examples of molecules comprisingan amide group and further comprising a pH sensitive chiral centerinclude, but are not limited to, certain oligosaccharides,polysaccharides, and amino acids.

As evidenced by the attached Examples, cleavage of amide bonds in amolecule using hydroxylamine or salts thereof can also be achievedwithout cleaving common protecting groups present in the molecule.

According to embodiments, the molecule comprising an amide group furthercomprises a pH sensitive protecting group. By “pH sensitive protectinggroup”, we mean a protecting group which is cleaved off under high orlow pH conditions. By high pH in this context we generally mean a pH of12 or higher (e.g. concentrated NaOH or the like). By low pH in thiscontext we generally mean a pH of 2 or lower (e.g. concentrated HCl orthe like). Examples of pH sensitive protecting groups include, but arenot limited to Boc (tert-Butyloxycarbonyl), Fmoc(9-Fluorenylmethyloxycarbonyl), Cbz (Carbobenzyloxy), i-PrCO, t-BuCO andTr (triphenylmethyl).

According to some embodiments, the molecule comprising an amide group isa biopolymer comprising acetyl groups. According to some embodiments,the biopolymer comprising acetyl groups is a glycosaminoglycan.According to some embodiments, the biopolymer comprising acetyl groupsis selected from the group consisting of sulfated or non-sulfatedglycosaminoglycans such as hyaluronan, chondroitin, chondroitinsulphate, heparan sulphate, heparosan, heparin, dermatan sulphate andkeratan sulphate, preferably hyaluronic acid, chondroitin andchondroitin sulfate, and mixtures thereof. According to someembodiments, the biopolymer comprising acetyl groups is hyaluronic acid.In some embodiments, the biopolymer is a hyaluronic acid gel. In someembodiments, the biopolymer is a hyaluronic acid gel crosslinked by1,4-butanediol diglycidyl ether (BDDE).

Hyaluronic acid is one of the most widely used biocompatible polymersfor medical use. Hyaluronic acid and the other GAGs are negativelycharged heteropolysaccharide chains which have a capacity to absorblarge amounts of water. Hyaluronic acid and products derived fromhyaluronic acid are widely used in the biomedical and cosmetic fields,for instance during viscosurgery and as a dermal filler.

According to embodiments, a product formed by the cleavage of the amidebond of step b) is an amine.

According to embodiments, the method further comprises the step

c) recovering a product, preferably an amine, formed by the reaction ofstep b).

The recovery in step c) may comprise any suitable organic syntheticwork-up or purification technique or combination of techniques.

The reaction temperature in step b) is preferably selected so as not tocause excessive degradation of the molecule and so as to preserveprotecting groups and/or chiral centres. The reaction may generally beperformed at a temperature of 200° C. or less, such as a temperature of150° C. or less. According to embodiments, the reaction in step b)comprises reacting the molecule comprising an amide group with thehydroxylamine or salt thereof at a temperature of 100° C. or less.According to embodiments, the reaction in step b) comprises reacting themolecule comprising an amide group with the hydroxylamine or saltthereof at a temperature in the range of 10-100° C., preferably 20-90°C., preferably 30-70° C., preferably 30-50° C. The temperature may forexample be in the range of 70-90° C., such as about 80 ° C., or in therange of 30-50° C., such as about 40° C.

The reaction time in step b) depends on the desired degree of amidecleavage. The reaction time is preferably selected so as not to causeexcessive degradation of the molecule and so as to preserve protectinggroups and/or chiral centres, and is also dependent on the temperatureand pH. The reaction time may generally be anywhere from 5 minutes to200 hours or more. According to some embodiments, the reaction in stepb) comprises reacting the molecule comprising an amide group with thehydroxylamine or salt thereof for 2-200 hours. According to someembodiments, the reaction in step b) comprises reacting the moleculecomprising an amide group with the hydroxylamine or salt thereof for2-150 hours, preferably 5-150 hours, preferably 5-100 hours. In otherembodiments, e.g. where a higher temperature or pH is used, the reactiontime can be much shorter, such as in the range of 5 minutes to 2 hours,in the range of 30 minutes to 2 hours, or in the range of 1-2 hours.Likewise, under otherwise mild reaction conditions, the reaction timecan be much longer than 200 hours.

The cleavage of the amide bond is preferably achieved using ahydroxylamine salt. The hydroxylamine salt refers to a salt formed byhydroxylamine and an acid. The hydroxylamine salt may for example be asalt formed by hydroxylamine and an acid selected from the groupconsisting of mineral acids and organic acids or mixtures thereof.

According to embodiments, the hydroxylamine salt is a salt formed byhydroxylamine and a mineral acid. According to embodiments, the acid isselected from the group consisting of sulfuric acid, hydrochloric acid,hydroiodic acid, hydrobromic acid and phosphoric acid, and combinationsthereof. Preferred mineral acids include hydrochloric acid, hydroiodicacid and hydrobromic acid. A particularly preferred mineral acid ishydroiodic acid.

According to embodiments, the hydroxylamine salt is a salt formed byhydroxylamine and an organic acid. According to embodiments, the acid isselected from the group consisting of acetic acid, propionic acid,pivalic acid, citric acid, oxalic acid, malonic acid, lactic acid,benzoic acid, and halogenated carboxylic acids, such as trifluoroaceticacid (TFA) and trichloroacetic acid, and combinations thereof.

According to embodiments, the acid is selected from the group consistingof acetic acid, propionic acid, pivalic acid, and a halogenatedcarboxylic acid, preferably trifluoroacetic acid, and combinationsthereof. According to embodiments, the acid is a halogenated carboxylicacid, preferably trifluoroacetic acid.

According to embodiments, the hydroxylamine salt is a salt formed byhydroxylamine and an acid selected from the group consisting ofhydrochloric acid, hydroiodic acid and hydrobromic acid, propionic acid,pivalic acid and trifluoroacetic acid.

The reaction in step b is preferably performed in a solvent capable ofat least partially dissolving both the molecule comprising an amidegroup and the hydroxylamine or salt thereof. The solvent may for examplebe water or an organic solvent or a mixture thereof. Non-limitingexamples of preferred solvents include water or a mixture of water and alower alcohol, such as ethanol. However, may other solvents would beuseful, depending on the particular molecule comprising the amide groupto be cleaved, and the selection of hydroxylamine or salt thereof. Oneexample of a useful organic solvent is tetrahydrofuran (THF).

According to embodiments, the reaction in step b) comprises reacting themolecule comprising an amide group with hydroxylamine in water.

The method may preferably be performed in water or aqueous solution,optionally further comprising another solvent, such as ethanol. Thusaccording to some embodiments, step b) comprises contacting a moleculecomprising an amide group with hydroxylamine in water so that an aqueousmixture or solution of the molecule and the hydroxylamine is formed.

According to embodiments, the concentration of hydroxylamine in step b)is at least 10% by weight, preferably at least 20% by weight, preferablyat least 30% by weight. A higher concentration of hydroxylamine mayincrease the reaction rate.

Hydroxylamine is often provided in the form of an aqueous solution,typically at a concentration of 50% by weight. In some embodiments, themolecule comprising an amide group may be mixed and dissolved directlyin the aqueous solution of hydroxylamine, optionally diluted.Alternatively, a solid salt of hydroxylamine, for example hydroxylaminehydrochloride or hydroxylamine sulfate, can be dissolved in an aqueoussolution of the molecule comprising an amide group. Adding a salt ofhydroxylamine, and converting the salt to hydroxylamine, may be done asan alternative or as a complement to dissolving the molecule comprisingan amide group in an aqueous solution of hydroxylamine.

The molar concentration of hydroxylamine in the reaction mixture ispreferably in the range of 5-20 M. For example, a concentration ofhydroxylamine of 50% by weight roughly corresponds to a molarconcentration of 16 M.

The inventors have surprisingly found that when a hydroxylamine salt isused instead of hydroxylamine itself, the same reaction rate can beachieved with a significantly lower molar concentration. Thus, the molarconcentration of hydroxylamine salt in the reaction mixture ispreferably in the range of 0.01-10 M, preferably in the range of 0.1-5M.

According to some embodiments, the molecule comprising an amide group isdissolved in an aqueous solution of hydroxylamine or salt thereof instep a). According to some embodiments, a salt of hydroxylamine isdissolved in an aqueous solution of a molecule comprising an amide groupin step a). According to some embodiments, the molecule comprising anamide group is dissolved in an aqueous solution of hydroxylamine, and asalt of hydroxylamine is dissolved in the aqueous solution of themolecule comprising an amide group in hydroxylamine.

The pH in the reaction step b) is preferably selected so as not to causeexcessive degradation of the molecule and so as to preserve protectinggroups and/or chiral centres. The pH of a 50% v/v solution ofhydroxylamine in water is 10.2. According to some embodiments, thereaction in step b) is performed at a pH value in the range of 4-12.According to some embodiments, the reaction in step b) is performed at apH value in the range of 9-11. According to some embodiments, thereaction in step b) is performed at a pH value in the range of 4-9,preferably in the range of 6-8.

The inventors have found through extensive experimentation that additionof a pH reducing agent can significantly increase the reaction rate ofthe reaction in step b), particularly when hydroxylamine is used. Thiseffect is both surprising and highly advantageous. It is noted that acorresponding addition of a pH reducing agent to a hydrazine amidecleavage reaction did not result in any increase of the reaction rate. Alower pH value during the reaction is also preferred in order to avoidexcessive degradation of the molecule and so as to preserve protectinggroups and/or chiral centres.

Thus, according to some embodiments, the pH of the reaction is loweredby addition of a pH reducing agent. According to some embodiments, thepH of the reaction is lowered to a value in the range of 4-9, preferablyin the range of 6-8, by addition of a pH reducing agent. The pH reducingagent may for example be selected from the group consisting of mineralacids, organic acids and pH reducing salts, and combinations thereof.

According to embodiments, the pH reducing agent is selected from thegroup consisting of mineral acids, organic acids and pH reducing salts,and combinations thereof.

According to embodiments, the pH reducing agent is a mineral acid.According to embodiments, the pH reducing agent is selected from thegroup consisting of sulfuric acid, hydrochloric acid, hydroiodic acid,hydrobromic acid and phosphoric acid, and combinations thereof.

According to embodiments, the pH reducing agent is an organic acid.According to embodiments, the pH reducing agent is selected from thegroup consisting of acetic acid, propionic acid, pivalic acid, citricacid, oxalic acid, malonic acid, lactic acid, benzoic acid, andhalogenated carboxylic acids, such as trifluoroacetic acid andtrichloroacetic acid, and combinations thereof. According toembodiments, the pH reducing agent is selected from the group consistingof acetic acid, propionic acid, pivalic acid, and a halogenatedcarboxylic acid, preferably trifluoroacetic acid, and combinationsthereof. According to embodiments, the pH reducing agent is ahalogenated carboxylic acid, preferably trifluoroacetic acid.

According to embodiments, the pH reducing agent is a pH reducing salt.According to embodiments, the pH reducing agent is selected from thegroup consisting of ammonium chloride, ammonium bromide, ammoniumiodide, hydroxylamine hydrochloride and hydroxylamine sulfate, andcombinations thereof. According to embodiments, the pH reducing agent isselected from the group consisting of hydroxylamine hydrochloride orhydroxylamine sulfate, preferably hydroxylamine hydrochloride.

According to some embodiments, the reaction in step b) is performed ininert atmosphere and/or in darkness.

The present invention is based on the inventive realization thathydroxylamine (NH₂OH) and particularly salts thereof can advantageouslybe used for cleaving an amide bond in a molecule comprising an amidegroup under mild reaction conditions. Thus according to other aspectsillustrated herein, there is provided the use of a hydroxylamine saltfor cleaving an amide bond in a molecule comprising an amide group.

The use may be further characterized as described above with referenceto the method described above.

Other aspects and preferred embodiments of the present invention will beevident from the following Examples and the appended claims.

The term “molecular weight” as used herein in connection with variouspolymers, e.g. polysaccharides, refers to the weight average molecularweight, M_(w), of the polymers, which is well defined in the scientificliterature. The weight average molecular weight can be determined by,e.g., static light scattering, small angle neutron scattering, X-rayscattering, and sedimentation velocity. The unit of the molecular weightis Da or g/mol.

The person skilled in the art realizes that the present invention by nomeans is limited to the preferred embodiments described herein. On thecontrary, many modifications and variations are possible within thescope of the appended claims. Additionally, variations to the disclosedembodiments can be understood and effected by the skilled person inpracticing the claimed invention, from a study of the drawings, thedisclosure, and the appended claims. In the claims, the word“comprising” does not exclude other elements or steps, and theindefinite article “a” or “an” does not exclude a plurality. The merefact that certain measures are recited in mutually different dependentclaims does not indicate that a combination of these measures cannot beused to advantage.

EXAMPLES

Without desiring to be limited thereto, the present invention will inthe following be illustrated by way of examples.

Analysis Methods

¹H NMR spectra were recorded on a BRUKER Biospin AVANCE 400spectrometer. Chemical shifts are reported as δ values downfield frominternal TMS in appropriate organic solutions. The purity and thestructures of the products were confirmed by LCMS (254 nm) on a Waters2690 photodiode array detector system using the following conditions:Column, Symmetry C-18; Solvent A, water 0.1% formic acid; Solvent B,CH₃CN; flow rate, 2.5 ml/min; run time, 4.5 min; gradient, from 0 to100% solvent B; mass detector, micro mass ZMD. Purifications werecarried out directly by mass-triggered preparative LCMS Waters X-Terrareverse-phase column (C-18, 5 microns silica, 19 mm diameter, 100 mmlength, flow rate of 40 ml/minute) and decreasingly polar mixtures ofwater (containing 0.1% formic acid) and acetonitrile as eluent. Thefractions containing the desired compound were evaporated to dryness toafford the final compounds usually as solids.

Example 1 Preparation ofN-((2R,3R,4S)-1,3,4,5-tetrahydroxy-6-(trityloxy)hexan-2-yl)acetamide

A solution ofN-((2R,3S,5S)-2,4,5-trihydroxy-6-trityloxymethyl-tetrahydro-pyran-3-yl)-acetamide(556 mg, 1.20 mol, 1.00 eq.) in a mixture of THF-H₂O (20 ml, 4:1) atr.t., was treated with solid sodium borohydride (49.92 mg, 1.32 mol,1.10 eq.) [gas evolution]. The reaction mixture was stirred at r.t. for2 h, concentrated to dryness to affordN-((2R,3R,4S)-1,3,4,5-tetrahydroxy-6-(trityloxy)hexan-2-yl)acetamide(500 mg, 89.54%) as a white solid that was used without furtherpurification.

LCMS: t_(R)=1.01 min., purity=100%; ES+, 464.26 (M−H)⁻.

Example 2 Deacetylation ofN-((2R,3R,4S)-1,3,4,5-tetrahydroxy-6-(trityloxy)hexan-2-yl)acetamide

A suspension ofN-((2R,3R,4S)-1,3,4,5-tetrahydroxy-6-(trityloxy)hexan-2-yl)acetamide (1eq) in hydroxylamine (10 volumes) was either treated with acid additivesto lower the pH to 7 or not as set out in Table 1, Examples 1-10. Themixture was heated at 80° C. until full conversion of the deacetylationwas reached. Deacetylation ofN-((2R,3R,4S)-1,3,4,5-tetrahydroxy-6-(trityloxy)hexan-2-yl)acetamidewith hydrazine (pH 13) under the same conditions as in Example 2-1 isalso included as Example 2-10.

The results are displayed in Table 1. The results show that thedeacetylation procedure proceeds considerably faster with hydroxylaminethan with hydrazine, and is significantly by the addition of a pHreducing agent.

TABLE 1 Solvent Time to reach Example (50 vols)* Additive pH 100%conversion 2-1 50% NH₂OH (aq) None 10.2 72 h  2-2 50% NH₂OH (aq) HCl 712 h  2-3 50% NH₂OH (aq) HBr 7 9 h 2-4 50% NH₂OH (aq) HI 7 5 h 2-5 50%NH₂OH (aq) H₂SO₄ 7 29 h  2-6 50% NH₂OH (aq) CH₃COOH 7 6 h 2-7 50% NH₂OH(aq) TFA 7 4 h 2-8 50% NH₂OH (aq) (CH₃)₃COOH 7 5 h 2-9 50% NH₂OH (aq)CH₃CH₂COOH 7 8 h 2-10 NH₂NH₂•H₂O None 13 120 h 

The reaction mixtures were purified directly by Preparative LCMS toafford (2R,3R,4S)-2-amino-6-(trityloxy)hexane-1,3,4,5-tetraol as a whitesolid.

LCMS: t_(R)=0.88 min., purity=99%; ES+, 422.11 (M−H)⁻.

¹H NMR (DMSO-d₆) δ: 7.47-7.37 (m, 6H), 7.30 (dd, J=8.3, 6.7 Hz, 6H),7.26-7.15 (m, 3H), 3.92 (m, 1H), 3.83-3.74 (m, 1H), 3.62-3.53 (m, 1H),3.52-3.41 (m, 1H), 3.34-3.27 (m, 1H), 3.22-3.16 (m, 1H), 3.13-3.04 (m,1H), 3.01-2.91 (m, 1H).

Example 3 Preparation of N-(4-aminophenethyl)acetamide

A 4-(2-aminoethyl)aniline (1.50 g; 11.01 mmol; 1.00 eq.) was added neatp-cresyl acetate (1.65 g, 11.0 mmol, 1.00 eq.) and the reaction mixturewas stirred at room temperature for 30 h. The resulting orange solutionwas absorbed directly on silica gel and purified by flash chromatography(silica gel, DCM/MeOH 0-5%) to afford N-(4-aminophenethyl)acetamide(1.76 g, 89.7% yield). LCMS: t_(R)=0.58 min., purity=99.5%; ES+, 179.5(M+H)⁺. ¹H-NMR (400 MHz, DMSO-d₆) δ 1.78 (s, 3H), 2.50 (m, 2H hidden byDMSO signal) 3.14 (m, 2H), 4.83 (s, 2H), 6.49 (d, J=7.5 Hz, 2H), 6.84(d, J=7.5 Hz, 2H), 7.82 (s, 1H).

Example 4 Preparation of tert-butyl(4-(2-acetamidoethyl)phenyl)carbamate

To a stirred solution of N-[2-(4-Amino-phenyl)-ethyl]-acetamide (500 mg,2.81 mmol, 1.00 eq.) in DCM (20 ml) at r.t., was added triethylamine(0.51 ml, 3.65 mmol, 1.30 eq.) followed by di-tert-butyl dicarbonate(673.48 mg, 3.09 mmol, 1.10 eq.). The reaction mixture is stirred atr.t. for 1 h, washed with water (5 ml), a saturated solution of NaHSO₄(aq) (5 ml) and water (3×5 ml), dried over MgSO₄ and concentrated todryness to afford tert-butyl (4-(2-acetamidoethyl)phenyl)carbamate (496mg, 63% yield) as a pale orange solid. LCMS: t_(R)=1.11 min.,purity=100%; ES+, 279.5 (M+H).

¹H-NMR (DMSO-d₆) δ 1H NMR (400 MHz, DMSO-d6) δ 1.57 (s, 9H), 1.87 (s,3H), 2.75-2.64 (m, 2H), 3.36-3.20 (m, 2H), 7.27-7.07 (m, 2H), 7.45 (d,J=8.3 Hz, 2H), 7.94 (t, J=5.6 Hz, 1H), 9.31 (s, 1H).

Example 5 Preparation of NH₂OH.Hl

To a stirred solution of 50% NH₂OH (aq) (9.28 ml, 0.15 mol, 1.00 eq) at0° C. was added carefully dropwise 57% Hl (aq) over a period of 5minutes until a pH of 7 was achieved. A dense white crystalline solidformed that was collected by filtration, washed carefully with ice coldwater to afford hydroxylamine hydrogen iodide (6.80 g, 28%).

Example 6 Preparation of NH₂OH.TFA

To a stirred solution of 50% NH₂OH (aq) (9.28 ml, 0.15 mol, 1.00 eq) at0° C. was added carefully dropwise TFA over a period of 5 minutes untila pH of 7 was achieved. The reaction mixture was concentrated undernitrogen sparging to afford hydroxylamine.trifluoroacetate (11.0 g, 98%)as clear colourless oil.

Example 7 Comparative Studies of NH₂OH and Salts Thereof Versus CommonlyUsed Transamidation Agents Such as NH₂NH₂.H₂O and NaOH

To a stirred solution/suspension of tert-butyl(4-(2-acetamidoethyl)phenyl) carbamate (50 mg, 0.18 mmol) in the chosensolvent (5 volumes) was added the salt (5 eq) and the resulting mixturewas heated at 80° C. for the time necessary to complete the reaction.The results are displayed in Table 2. The results show that thedeacetylation procedure proceeds quickly with for example hydroxylaminehydrogen iodide (Example 7-3) or hydroxylamine trifluoroacetate (Example7-9), even when the relative concentration of hydroxylamine in the saltsis much lower than the concentration of hydroxylamine alone in Example7-1. LCMS: t_(R)=0.81 min., purity=100%; ES+, 237.51(M+H)⁺.

¹H-NMR (DMSO-d₆) δ 1H NMR (400 MHz, DMSO-d₆) δ 9.26 (s, 1H), 8.40 (s,1H), 7.38 (d, J=8.0 Hz, 2H), 7.11 (d, J=8.0 Hz, 2H), 2.89 (m, 2H),2.80-2.63 (m, 2H), 1.47 (s, 9H) (isolated as formate salt).

TABLE 2 Solvent 1 h (% 2 h (% 4 h (% Example (5 vols)* Additive pHconv.) conv.) conv.) 7-1 50% NH₂OH None 10.2 34.8 64.7 83.0 (aq) 7-2 50%NH₂OH 5 eq 9 48.6 83.5 97.0 (aq) NH₂OH•HI 7-3 EtOH/H₂O 5 eq 7 63.8 85.898.9 (4:1) NH₂OH•HI 7-4 NH₂NH₂•H₂O None 13 13.6 34.9 35.2 7-5 NH₂NH₂•H₂O5 eq 13 57.9 86.9 97.4 NH₂OH•HI 7-6 EtOH (4 4N NaOH (aq) 14 3.7 11.6314.5 vols) (1 vol) 7-7 EtOH/H₂O 5 eq 7 3.4 5.8 17.2 (4:1) NH₂OH•HCl 7-8EtOH/H₂O 5 eq 7 0 0.2 0.7 (4:1) NH₂OH•H₂SO₄ 7-9 EtOH/H₂O 5 eq 7 34.272.4 91.3 (4:1) NH₂OH•TFA 7-10 EtOH/H₂O 5 eq NH₄I 7 0 0 0 (4:1) *Volume= 1 g = 1 ml = 1 volume

Example 8 Preparation and Deacetylation of Reduced HA-4 by Hydroxylamine

Diaminotetra-HA (DA-4HA) was synthesized according to the below scheme:

Step 1

A solution of HA-4 (500 mg, 0.61 mmol) in water (5 ml) at roomtemperature was treated with sodium borohyride (23.05 mg, 0.61 mmol) andthe resulting solution was stirred for 3 h, concentrated to dryness toafford the reduced product 1 (532 mg, assumed 100%) as a white foam.

LCMS (t_(r)=0.28 min., ES+=779.4 (M−2 Na+2H)

Step 2

The reduced product 1 (532 mg) was dissolved in aqueous NH₂OH (5 ml, 50%v/v/) and solid NH₄I (100 mg) was added. The resulting suspension washeated at 70° C. for 48 h, cooled to room temperature and concentratedto dryness to afford a residue. The residue was precipitated in neatEtOH and the resulting precipitate was collected by filtration and driedto a constant weight to afford the a 1:1 mixture of diamine 2 andmono-amine 3 in quantitative yield.

2: LCMS (t_(r)=0.16 min., ES+=695.36 (M−2 Na+2H)

3: LCMS (t_(r)=0.19 min., ES+=737.47 (M−2 Na+2H)

Example 9 Deacetylation of Reduced HA-4 by NH₂OH.Hl

Reduced HA-4 (532 mg) prepared as described in Step 1 of Example 26, isdissolved in EtOH—H₂O (2.5 ml, 1:1) and solid NH₂OH.Hl (491 mg, 3.05mmol) is added. The resulting suspension is heated at 80° C. for 6 h,cooled to room temperature and the reaction mixture is purified byPreparative HILIC chromatography to afford deacetylated HA-4 as a whitesolid.

Deacetylated HA-4: LCMS (t_(r)=0.16 min., ES+=695.36 (M−2 Na+2H)

Example 10 Deacetylation of Hyaluronic Acid by Hydroxylamine

0.2 g or 20 g of HA (Mw 2 500 kDa, DoA 100%) was solubilised inhydroxylamine (Sigma-Aldrich 50 vol % solution), or a mixture ofhydroxylamine/water as set out in Table 3. The solution was incubated indarkness and under argon at 30-70° C. for 5-353 hours. After incubation,the mixture was precipitated by ethanol. The obtained precipitate wasfiltered, washed with ethanol and then re-dissolved in water. Thesolution was purified by ultrafiltration and subsequently lyophilized toobtain the deacetylated HA (de-Ac HA) as a white solid. Examples 10-1 to10-14 were performed using approx. 0.2 g HA and examples 10-15 to 10-16were performed using 20 g HA. The results are displayed in Table 3.Deacetylation by hydroxylaminolysis is more efficient, and conserves theMw of the HA backbone better as compared to hydrazinolysis (Example 11)and alkaline methods (Examples 12-13).

TABLE 3 Start NMR Temp Time Mw DoA Mw Example (° C.) (h) pH Conditions(kDa) (%) (kDa) 10-1 30 24 10 NH₂OH 2500 99  970^(a ) (50 wt % in water)10-2 30 72 10 NH₂OH 2500 98 1060^(a) (50 wt % in water) 10-3 30 196 10NH₂OH 2500 95 1060^(a) (50 wt % in water) 10-4 40 24 10 NH₂OH 2500 981050^(a) (50 wt % in water) 10-5 40 72 10 NH₂OH 2500 95  980^(a) (50 wt% in water) 10-6 40 353 10 NH₂OH 2500 80  490^(a) (50 wt % in water)10-7 40 24 10 NH₂OH 2500 99 1090^(a) (35 wt % in water) 10-8 40 24 10NH₂OH 2500 100 1130^(a) (20 wt % in water) 10-9 40 24 10 NH₂OH 1000 98 670^(b) (50 wt % in water) 10-10 55 5 10 NH₂OH 2500 99 1010^(a) (50 wt% in water) 10-11 55 72 10 NH₂OH 2500 86  740^(a) (50 wt % in water)10-12 55 120 10 NH₂OH 2500 78  400^(b ) (50 wt % in water) 10-13 60 2410 NH₂OH 2500 92  930^(b) (50 wt % in water) 10-14 70 24 10 NH₂OH 250086  720^(b) (50 wt % in water) 10-15 40 72 10 NH₂OH 2500 95 1870^(b) (50wt % in water) 10-16 55 72 10 NH₂OH 2500 89 1050^(b) (50 wt % in water)^(a) SEC-UV ^(b) SEC-MALS

Example 11 Deacetylation of Hyaluronic Acid byHydrazinolysis—Comparative Example

0.2 g of HA (Mw 2 500 kDa, DoA 100%) was solubilised in 10 mL of a 1%solution of hydrazine sulphate in hydrazine monohydrate. The reactiontook place in dark and under argon at 30-55° C. for 24-120 hours. Themixture was precipitated by ethanol. The precipitate obtained wasfiltered, washed with ethanol and then re-dissolved in water. The finaldeacetylated HA product was obtained after ultrafiltration, andfreeze-dried. The results are displayed in Table 4. Deacetylation byhydrazinolysis gives more degradation of the HA backbone, i.e. lower Mwof the deacetylated product as compared to hydroxylaminolysis (Examples10-1 to 10-16).

TABLE 4 Mw (SEC Temp Time DoA MALS) Example (° C.) (h) pH Conditions (%)(kDa) 11-1 30 24 13 NH₂NH₂ + 100 220 NH₂NH₂H₂SO₄ 11-2 30 120 13 NH₂NH₂ +96 320 NH₂NH₂H₂SO₄ 11-3 40 48 13 NH₂NH₂ + 96 260 NH₂NH₂H₂SO₄ 11-4 40 12013 NH₂NH₂ + 92 170 NH₂NH₂H₂SO₄ 11-5 55 24 13 NH₂NH₂ + 93 60 NH₂NH₂H₂SO₄11-6 55 48 13 NH₂NH₂ + 89 70 NH₂NH₂H₂SO₄ 11-7 55 72 13 NH₂NH₂ + 83 40NH₂NH₂H₂SO₄ 11-8 55 120 13 NH₂NH₂ + 77 50 NH₂NH₂H₂SO₄

Example 12 Deacetylation of Hyaluronic Acid by Homogeneous AlkalineHydrolysis—Comparative Example

HA (1 000 kDa) was weighed to a reaction vessel, NaOH solution was addedand the reaction was mixed until a homogenous solution was obtained. Themixture was incubated without stirring and subsequently diluted withwater and EtOH. The mixture was neutralized by adding 1.2 M HCl,precipitated by adding EtOH. The precipitate was washed with ethanol (70w/w %) followed by ethanol and dried in vacuum over night to obtain asolid. The results are displayed in Table 5.

Deacetylation by homogenous alkaline hydrolysis gives more degradationof the HA backbone, i.e. lower Mw of the deacetylated product ascompared to hydroxylaminolysis (Examples 10-1 to 10-16).

TABLE 5 Mw Temp Time DoA (SEC UV) Example (° C.) (h) pH Conditions (%)(kDa) 12 65 4 13 1M NaOH 99 10 (aq.)

Example 13 Deacetylation of Hyaluronic Acid by Heterogeneous AlkalineHydrolysis—Comparative Example

HA (1 000 kDa) was weighed to a reaction vessel and NaOH in EtOH (70%w/w %) was added. The heterogeneous mixture was incubated andsubsequently neutralized by addition of 1.2 M HCl. The precipitate waswashed with ethanol (75 w/w %) followed by ethanol and dried in vacuumover night to obtain a solid. The results are displayed in Table 6.

Deacetylation by heterogeneous alkaline hydrolysis gives moredegradation of the HA backbone, i.e. lower Mw of the deacetylatedproduct as compared to hydroxylaminolysis (Examples 10-1 to 10-16).

TABLE 6 Mw Temp Time DoA (SEC UV) Example (° C.) (h) Conditions (%)(kDa) 13 35 24 1.0M NaOH 99 60 (70% EtOH)

Further Examination of Substrate Scope and Chemoselectivity

Protection of N-[2-(4-Amino-phenyl)-ethyl]-acetamide with a variety ofwidely used protecting groups.

Example 14 Preparation of benzyl (4-(2-acetamidoethyl)phenyl)carbamate

To a stirred solution of N-[2-(4-Amino-phenyl)-ethyl]-acetamide (150 mg,0.84 mmol) in THF (2 ml) and water (0.5 ml), was added sodiumhydrogencarbonate (91.9 mg, 1.09 mmol) followed by benzyl chloroformate(151 mg, 0.88 mmol) at 0° C. over 1 minute. The reaction mixture wasstirred for 1 h, diluted with DCM (30 ml), washed with water (3×5 ml),dried (MgSO₄) to afford benzyl (4-(2-acetamidoethyl)phenyl)carbamate(224 mg, 85%) as a white solid: LCMS (t_(r)=1.13 min., ES+=313.68(M+H)); ¹H NMR (400 MHz, DMSO-d₆) δ 9.67 (s, 1H), 7.86 (t, J=5.6 Hz,1H), 7.51-7.27 (m, 7H), 7.17-7.02 (m, 2H), 5.14 (s, 2H), 3.29-3.11 (t,J=7.4 Hz, 2H), 2.63 (t, J=7.4 Hz, 2H), 1.78 (s, 3H); ¹³C NMR (101 MHz,DMSO-d₆) δ 169.02, 153.43, 137.18, 136.74, 133.58, 128.90, 128.49,128.11, 128.06, 118.33, 65.68, 39.07, 34.59, 22.65.

Example 15 Preparation of (9H-fluoren-9-yl)methyl (4-(2-acetamidoethyl)phenyl)carbamate

To a stirred solution of N-[2-(4-Amino-phenyl)-ethyl]-acetamide (150 mg,0.84 mmol) in THF (2 ml) and water (0.5 ml) was added sodiumhydrogencarbonate (91.9 mg, 1.09 mmol) followed by Fmoc-OSu (298 mg,0.88 mmol) at 0° C. The reaction mixture was stirred at r.t. for 1 h andthe resulting suspension was diluted with water (2 ml) and precipitatecollected by filtration washed with water (2 ml) and diethyl ether (5ml) to afford (9H-fluoren-9-yl)methyl(4-(2-acetamidoethyl)phenyl)carbamate (316 mg, 94%) as a white solid:LCMS (t_(r)=1.29 min., ES+=401.52 (M+H), 423.55 (M+Na)); ¹H NMR (400MHz, DMSO-d₆) δ 9.61 (s, 1H), 7.99-7.79 (m, 2H), 7.86 (t, J=5.6 Hz, 1H),7.75 (d, J=7.4 Hz, 2H), 7.50-7.28 (m, 6H), 7.09 (d, J=8.1 Hz, 2H), 4.83(s, 1H), 4.48 (d, J=6.7 Hz, 2H), 4.31 (t, J=6.6 Hz, 1H), 3.27 -3.07 (m,2H), 2.63 (t, J=7.4 Hz, 2H), 1.78 (s, 3H). ¹H NMR (400 MHz, DMSO-d₆) δ9.61 (s, 1H), 7.92 (d, J=7.4 Hz, 2H), 7.86 (t, J=5.6 Hz, 1H), 7.75 (d,J=7.4 Hz, 2H), 7.44 (ddd, J=8.1, 7.4, 1.2 Hz, 2H), 7.36 (td, J=7.4, 1.2Hz, 4H), 7.09 (d, J=8.1 Hz, 2H), 4.48 (d, J=6.7 Hz, 2H), 4.31 (t, J=6.7Hz, 1H), 3.26-3.12 (m, 2H), 2.68-2.58 (m, 2H), 1.78 (s, 3H). ¹³C NMR(101 MHz, DMSO-d₆) δ 169.02, 153.48, 143.85, 140.86, 137.13, 133.60,128.97, 128.86, 127.34, 127.16, 125.17, 121.43, 65.54, 46.71, 40.78,34.59, 22.66.

Example 16 Preparation of 2-(trimethylsilyl)ethyl (4-(2-acetamidoethyl)phenyl)carbamate

To a stirred solution of N-(4-aminophenethyl)acetamide (200 mg, 1.12mmol, 1 eq) and TEA (in DCM (10 ml) at 0° C., is added 4-nitrophenyl2-(trimethylsilyl)ethyl carbonate (286 mg, 1.01 mmol) over a period of 5minutes. The reaction mixture is stirred at room temperature overnight,diluted with DCM (10 ml), washed with a saturated aqueous solution ofNaHSO₄ (5 ml), a saturated solution of NaHCO₃ (aq) (5 ml), water (3×5ml), dried over MgSO₄ and concentrated to dryness to afford the titlecompound as a white solid: LCMS (t_(r)=1.25 min., ES+=323.47 (M+H),345.47 (M+Na)); ¹H NMR (400 MHz, DMSO-d₆) δ 9.37 (s, 1H), 7.80 (t, J=5.6Hz, 1H), 7.42-7.23 (d, J=8.3 Hz, 2H), 7.12-6.96 (d, J=8.3 Hz, 2H),4.17-3.97 (m, 2H), 3.22-3.06 (m, 2H), 2.57 (t, J=7.4 Hz, 2H), 1.76-1.67(m, 3H), 0.00 (s, 9H); ¹³C NMR (101 MHz, DMSO-d₆) δ 169.99, 153.70,137.39, 133.35, 128.82, 118.34, 67.07, 40.31, 34.59, 25.40, 22.65,−1.52.

Example 17 Preparation of 2,2,2-trichloroethyl (4-(2-acetamidoethyl)phenyl)carbamate

To a stirred solution of N-(4-aminophenethyl)acetamide (150 mg, 0.84mmol) in THF (2 ml) and water (0.5 ml) at 0° C., was added sodiumhydrogencarbonate (91.9 mg, 1.09 mmol) followed by trichloromethylchloroformate (175 mg, 0.88 mmol) (286 mg, 1.01 mmol) over a period of 1minute. The reaction mixture is stirred at room temperature for 1 h,diluted with DCM (10 ml), washed with water (3×5 ml), dried over MgSO₄and concentrated to dryness to afford the title compound (200 mg, 67%)as a white solid; LCMS (t_(r)=1.17 min., ES+=353.35 (M+H); ¹H NMR (400MHz, DMSO-d₆) δ 10.05 (s, 1H), 7.86 (t, J=5.6 Hz, 1H), 7.42 (d, J=8.1Hz, 2H), 7.19-7.02 (d, J=8.1 Hz, 2H), 4.94 (s, 2H), 3.27-3.10 (m, 2H),2.64 (t, J=7.4 Hz, 2H), 1.78 (s, 3H); ¹³C NMR (101 MHz, DMSO-d₆) δ169.03, 151.85, 136.52, 134.30, 129.00, 118.74, 96.05, 73.39, 39.99,34.59, 22.65.

Example 18 Preparation of methyl 4-(acetamidomethyl)benzoate

To a stirred suspension of methyl 4-(aminomethyl)benzoate hydrochloride(260 mg, 1.29 mmol) in DCM (5 mL) at r.t., were added triethylamine(0.39 ml, 2.84 mmol) followed by acetic anhydride (171 mg, 1.68 mmol)and the reaction mixture was stirred at r.t. for 1 h, diluted with DCM(10 mL) and washed with water (2 mL), a saturated aqueous solution ofNaHSO₄ (2 mL) and water (2×2 mL). The organic extract was concentratedto dryness to afford methyl 4-(acetamidomethyl)benzoate (232 mg, 87%) asa white solid: LCMS (t_(r)=0.92 min., ES+=208.42 (M+H)); ¹H-NMR (400MHz, DMSO-d₆) δ 8.42 (t, J=6.0 Hz, 1H), 8.03-7.82 (d, J=7.7 Hz, 2H),7.49-7.24 (d, J=7.7 Hz, 2H), 4.33 (d, J=6.0 Hz, 2H), 3.85 (s, 3H), 1.90(s, 3H); ¹³C NMR (DMSO-d₆) δ 169.40, 166.16, 145.42, 129.27, 127.10,52.07, 41.94, 34.59, 22.68.

Example 19 Preparation of 4-(Acetamidomethyl)-N-methylbenzamide

To a stirred suspension of 4-aminomethyl-N-methyl-benzamide (250 mg,1.52 mmol) in DCM (20 ml) at r.t., were added triethylamine (274 μl,1.98 mmol) followed by acetic anhydride (155 mg, 1.52 mmol). Theresulting suspension was stirred for 16 h at r.t. and the precipitatewas collected by filtration, washed with DCM (2 ml) and dried to aconstant weight to afford 4-(acetamidomethyl)-N-methylbenzamide (301 mg,94.07%) as a white solid: LCMS (t_(r)=0.66 min., ES+=207.40 (M+H);¹H-NMR (400 MHz, DMSO-d₆) δ 8.37 (t, J=5.7 Hz, 1H), 7.85-7.71 (m, 2H),7.37-7.23 (m, 2H), 4.29 (d, J=6.0 Hz, 2H), 2.78 (d, J=4.5 Hz, 3H), 1.89(s, 3H); ¹³C NMR (101 MHz, DMSO-d₆) δ 169.27, 166.43, 142.78, 133.08,127.11, 127.01, 41.86, 39.71, 26.25, 22.61.

Example 20 Preparation of 4-(Acetamidomethyl)-N,N-dimethylbenzamide

To a stirred suspension of 4-aminomethyl-N,N-dimethyl-benzamide (250 mg,1.40 mmol) in DCM (20 ml) at r.t., were added triethylamine (253 μl,1.82 mmol) followed by acetic anhydride (143 mg; 1.40 mmol). Theresulting solution was stirred for 16 h at r.t., washed with a saturatedsolution of NaHSO₄ (aq) and water. The organic phase was dried (MgSO₄)and concentrated to dryness to afford4-(Acetamidomethyl)-N,N-dimethylbenzamide (265 mg, 86%) as a pale yellowoil; LCMS (t_(r)=0.75 min., ES+=221.14 (M+H); ¹H-NMR (400 MHz, DMSO-d₆)δ 8.37 (s, 1H), 7.41-7.13 (m, 5H), 4.28 (d, J=6.0 Hz, 2H), 3.10-2.77 (m,6H), 1.89 (s, 3H); ¹³C NMR (101 MHz, DMSO-d₆) δ 170.06, 169.26, 140.9,134.97, 127.07, 127.01, 41.87, ((CH₃)₂NC═O—) under DMSO peak at40.28-38.97), 22.61.

Example 21 Preparation of tert-Butyl 4-(acetamidomethyl)benzoate

To a stirred suspension of 4-aminomethyl-benzoic acid tert-butyl ester(250 mg, 1.21 mmol) in DCM (20 ml) at r.t., were added triethylamine(217 μl, 1.57 mmol) followed by acetic anhydride (123 mg; 1.21 mmol).The resulting solution was stirred for 16 h at r.t., washed with asaturated solution of NaHSO₄ (aq) and water. The organic phase was dried(MgSO₄) and concentrated to dryness to afford tert-Butyl4-(acetamidomethyl)benzoate (291 mg, 97%) as a clear, colourless oil:LCMS (t_(r)=1.14 min., ES+=250.50 (M+H), 194.46 (M−^(t)Bu+H); ¹H NMR(400 MHz, DMSO-d₆) δ 8.41 (t, J=6.0 Hz, 1H), 7.90-7.77 (m, 2H),7.47-7.27 (m, 2H), 4.31 (d, J=5.9 Hz, 2H), 1.89 (s, 3H), 1.55 (s, 9H);¹³C NMR (101 MHz, DMSO-d₆) δ 169.32, 164.89, 144.94, 129.88, 129.10,127.22, 80.59, 41.90, 27.86, 22.59.

Example 22-30 Chemoselective Cleavage of Acetamides Over CommonCarbamate Protecting Groups Esters and Other Amides Example 22 GeneralDeacetylation Procedure

To a stirred solution of the ‘acetamide’ (50 mg, 1 eq) in EtOH—H₂O (4:1,5 volumes) was added NH₂OH.TFA solution (50% v/v, 5 eq) and thesuspension/solution was heated at 80° C. for 5 h, cooled to roomtemperature and purified directly by Mass Triggered Preparative LCMS toafford the desired compounds as their trifluoroacetate salts.

Example 23 Deacetylation of benzyl (4-(2-acetamidoethyl)phenyl)carbamate (Example 14) Using the General Procedure of Example 22

Benzyl (4-(2-aminoethyl)phenyl)carbamate was isolated as a white solid(41.2 mg, 67%) following the general procedure of Example 22.

LCMS (t_(r)=0.51 min., ES+271.31 (M+H); ¹H NMR (400 MHz, DMSO-d₆) δ 9.74(s, 1H), 7.81 (s, 3H), 7.53-7.27 (m, 7H), 7.18 (d, J=8.6 Hz, 2H), 5.15(s, 2H), 3.01 (t, J=7.9 Hz, 2H), 2.79 (m, 2H); ¹³C NMR (101 MHz,DMSO-d₆) δ 153.44, 137.84, 136.68, 131.15, 129.06, 128.50, 128.13,128.10, 118.52, 65.75, 40.10, 32.45.

Example 24 Deacetylation of 2,2,2-trichloroethyl (4-(2-acetamidoethyl)phenyl)carbamate (Example 17) Using the General Procedure of Example 22

2,2,2-Trichloroethyl (4-(2-aminoethyl)phenyl)carbamate was isolated awhite solid (45 mg, 75%) following the general procedure of Example 22.

LCMS (t_(r)=0.56 min., ES+311.12, 313.15, 315.09 (M+H); ¹H NMR (400 MHz,DMSO-d₆) δ 10.12 (s, 1H), 7.76 (s, 3H), 7.47 (d, J=8.7 Hz, 2H), 7.21 (d,J=8.7 Hz, 2H), 4.94 (s, 2H), 3.02 (dd, J=9.2, 6.6 Hz, 2H), 2.81 (dd,J=9.2, 6.6 Hz, 2H); ¹³C NMR (101 MHz, DMSO-d₆) δ 151.87, 137.18, 131.89,129.16, 118.95, 96.01, 73.41, 40.11, 32.53.

Example 25 Deacetylation of 2-(trimethylsilyl)ethyl(4-(2-acetamidoethyl) phenyl)carbamate (Example 16) Using the GeneralProcedure of Example 22.

2-(Trimethylsilyl)ethyl (4-(2-aminoethyl)phenyl)carbamate (48 mg, 78%)was isolated as an off-white solid following the general procedure ofExample 22.

LCMS (t_(r)=0.93 min., ES+281 (M+H); ¹H NMR (400 MHz, DMSO-d₆) δ 9.45(s, 1H), 7.76 (s, 3H), 7.36 (d, J=8.3 Hz, 2H), 7.10 (d, J=8.3 Hz, 2H),4.19-4.01 (m, 2H), 3.05-2.87 (m, 2H), 2.73 (dd, J=9.3, 6.6 Hz, 2H),1.08-0.82 (m, 2H), 0.00 (s, 9H); ¹³C NMR (101 MHz, DMSO-d₆) δ 153.69,138.06, 130.92, 128.98, 118.50, 62.12, 40.12, 32.46, 17.40, −1.39.

Example 26 Deacetylation of (9H-fluoren-9-yl)methyl(4-(2-acetamidoethyl) phenyl)carbamate (Example 15) Using the GeneralProcedure of Example 22

(9H-Fluoren-9-yl)methyl (4-(2-aminoethyl)phenyl)carbamate (35 mg, 59%)was isolated as an off-white solid following the general procedure ofExample 22.

LCMS (t_(r)=0.99 min., ES+395.47 (M+H); ¹H NMR (400 MHz, DMSO-d₆) δ 9.67(s, 1H), 7.92 (d, J=7.5 Hz, 2H), 7.75 (d, J=7.4 Hz, 2H), 7.51-7.28(overlapping signals, 9H), 7.16 (d, J=8.2 Hz, 2H), 4.49 (d, J=6.6 Hz,2H), 4.31 (t, J=6.6 Hz, 1H), 2.96 (m, 2H), 2.84-2.59 (m, 2H).

Example 27 Deacetylation of 4-(acetamidomethyl)benzoate (Example 18)

To a stirred solution of 4-(acetylamino-methyl)-benzoic acid methylester (40.0 mg, 0.19 mmol) in THF (200 μL) was added NH₂OH.TFA (85.15mg, 0.58 mmol) and the solution was heated at 80° C. for 2 h, cooled tor.t. and purified by Prep LCMS pour donner methyl4-(aminomethyl)benzoate (22.0 mg, 69%) as a trifluoroacetate salt: LCMS(t_(r)=0.92 min., ES+=166.37 (M+H), 149.72 (M−NH₃)+H); ¹H-NMR (400 MHz,DMSO-d₆) δ 8.32 (br s, 3H), 8.09-7.94 (d, J=7.5 Hz, 2H), 7.71-7.50 (d,J=7.5 Hz, 2H), 4.14 (s, 2H), 3.87 (s, 3H); ¹³C NMR (DMSO-d₆) δ 165.93,163.06, 139.34, 129.66, 129.43, 129.11, 52.31, 41.95.

Example 28 Deacetylation of 4-(Acetamidomethyl)-N-methylbenzamide(Example 19) Using the General Procedure of Example 22

4-(Aminomethyl)-N-methylbenzamide (22 mg, 54%) was isolated as a whitesolid following the general procedure of Example 22.

LCMS (t_(r)=0.15 min., ES+165 (M+H); ¹H NMR (400 MHz, DMSO-d₆) δ 8.35(d, J=4.5 Hz, 1H), 7.84-7.69 (d, 2H), 7.32 (d, J=7.9 Hz, 2H), 7.20 (s,1H), 4.17 (d, J=5.8 Hz, 2H), 2.78 (d, J=4.5 Hz, 3H); ¹³C NMR (101 MHz,DMSO-d₆) δ 166.55, 142.78, 133.08, 127.01, 126.70, 26.25.

Example 29 Deacetylation of 4-(Acetamidomethyl)-N,N-dimethylbenzamide(Example 20) Using the General Procedure of Example 22

4-(Aminomethyl)-N,N-dimethylbenzamide (24 mg, 59%) was was isolated as awhite solid following the general procedure of Example 22.

LCMS (t_(r)=0.15 min., ES+179 (M+H); ¹H NMR (400 MHz, DMSO-d₆) δ7.48-7.22 (m, 4H), 3.75 (s, 1H), 2.94 (2 s, rotmamers, 6H); ¹³C NMR (101MHz, DMSO-d_(b 6)) δ 166.55, 145.40, 134.43, 127.10, 126.70, 45.70,26.25.

Example 30 Deacetylation of tert-Butyl 4-(acetamidomethyl)benzoate(Example 21) Using the General Procedure of Example 22

Tert-Butyl 4-(aminomethyl)benzoate (29 mg, 70%) was isolated as a clear,colourless oil following the general procedure of Example 22.

LCMS (t_(r)=0.79 min., ES+208 (M+H); ¹H NMR (400 MHz, DMSO-d₆) δ7.92-7.78 (d, J=8.0 Hz, 2H), 7.36 (d, J=8.0 Hz, 1H), 3.78 (s, 2H), 1.55(s, 9H); ¹³C NMR (101 MHz, DMSO-d6) δ 164.44, 144.13, 134.21, 129.03,126.94, 80.53, 43.71, 27.88.

The invention claimed is:
 1. A method for cleaving N-acyl amide bonds,comprising: reacting a molecule comprising a N-acyl amide group and a pHsensitive protecting group with a hydroxylamine salt to cleave the amidebond of the N-acyl amide group; wherein the amide group is a primary,secondary, or tertiary amide group.
 2. The method according to claim 1,further comprising recovering a product formed by reacting the moleculecomprising the N-acyl amide group and the pH sensitive protecting groupwith the hydroxylamine salt.
 3. The method according to claim 1, whereinthe reacting is at a temperature of 100° C. or less.
 4. The methodaccording to claim 1, wherein the reacting is for 2-200 hours.
 5. Themethod according to claim 1, wherein the hydroxylamine salt is a saltformed by hydroxylamine and an acid selected from the group consistingof mineral acids, organic acids, and mixtures thereof.
 6. The methodaccording to claim 1, wherein the hydroxylamine salt is a salt formed byhydroxylamine and an acid selected from the group consisting ofhydrochloric acid, hydroiodic acid, hydrobromic acid, acetic acid,propionic acid, pivalic acid, citric acid, oxalic acid, malonic acid,lactic acid, benzoic acid, halogenated carboxylic acids, and mixturesthereof.
 7. The method according to claim 1, wherein the hydroxylaminesalt is a salt of hydroxylamine and hydroiodic acid or halogenatedcarboxylic acids comprising trifluoroacetic acid (TFA), trichloroaceticacid, or mixtures thereof.
 8. The method according to claim 1, having aconcentration of the hydroxylamine salt in the range of 0.1-5 M.
 9. Themethod according to claim 1, wherein the reaction is performed in asolvent capable of dissolving the hydroxylamine salt.
 10. The methodaccording to claim 1, wherein the reaction is performed in water or anaqueous solution.
 11. The method according to claim 1, wherein thereaction is performed at a pH value in the range of 4-12.
 12. The methodaccording to claim 1, wherein the reaction is performed at a pH value inthe range 9-11.
 13. The method according to claim 1, wherein the pH ofthe reaction is lowered to a value in the range of 4-9, by addition of apH reducing agent selected from the group consisting of mineral acids,organic acids and pH reducing salts, and combinations thereof.
 14. Themethod according to claim 1, wherein the N-acyl amide group is aN-acetyl amide.